Acute and Sub-acute Stent Thrombosis after Emergency Percutaneous Coronary Revascularization with Drug-eluting Stents: A Prospective Observational Study of Incidence, Predictors, and Outcomes| Chapter 9 | Perspective of Recent Advances in Medical Research Vol. 5

 This phase aimed to decide acute and sub-severe Stent thrombosis (ST)  occurrence, predictors, and outcomes following in position or time primary percutaneous coronary invasion (PCI).Patients who had sustained primary PCI at a tertiary care cardiac center were contained in this potential observational study. All subjects were followed up on 30 days after their beginning hospitalization to visualize if they developed severe or subacute ST.An aggregate of 1756 patients were included accompanying 79% (1388) male patients and mean age was 55.59 ± 11.23 age. The findings presented that the incidence of ST was 4.9% (86) with 1.3% (22) severe and 3.6% (64) sub-severe. ST was categorized as positive in 3.3% (58) and probable in 1.6% (28). Independent predictor of ST were seen to be male common (odds percentage (OR); 2.51 [1.21–5.2]), left ventricular end-diastolic pressure ≥ 20 mmHg (OR; 2.55 [1.31–4.98]), and pre-procedure thrombolysis in heart attack (TIMI) flow 0 (OR; 3.27 [1.61–6.65]). After primary PCI, we establish a significant number of patients the one were susceptible to severe or subacute ST. Male gender, LVEDP, and pre-process TIMI flow grade can all be used to identify and manage extreme-risk patients.

Author(s) Details:

Rajesh Kumar,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Ali Ammar,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Tahir Saghir,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Jawaid Akbar Sial,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Jehangir Ali Shah,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Ashok Kumar,
National Institute of Cardiovascular Diseases (NICVD), Hyderabad, Pakistan.

Abdul Hakeem Shaikh,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Abdul Samad Achakzai,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Nadeem Qamar,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Musa Karim,
National Institute of Cardiovascular Diseases (NICVD), Karachi, Pakistan.

Please see the link here: https://stm.bookpi.org/PRAMR-V5/article/view/9145

Relationships between Myocardial Damage Biomarkers with Infarct Size and Ejection Fraction Impairment Assessed by Cardiac Magnetic Resonance | Chapter 8 | New Frontiers in Medicine and Medical Research Vol. 8

 Acute myocardial infarction (AMI) is the most common cause of illness and mortality in the globe. The largest predictors of post-AMI mortality are the final infarct size (FIS) and left ventricular ejection fraction (LVEF), with cardiac magnetic resonance (CMR) being the gold standard method for measuring them. Biomarkers for myocardial injury, such as creatine kinase (CK) and myocardial creatine kinase (CKMB), are currently utilised to diagnose AMI and quantify the amount of myocardial damage. It would be reasonable to employ them as predictors of FIS and LVEF; however, present evidence is lacking.

On the basis of their correlation in patients having primary coronary angioplasty (PCA) following ST-elevation acute myocardial infarction, establish the potential power of plasma CK and CKMB levels as predictors of FIS and LVEF deterioration, respectively (STEMI).

The PREVEC Trial (ISRCTN registry: 56034553), a multicentric, randomised, double-blind clinical research, was retrospectively examined. Sixty-seven individuals with STEMI who were scheduled for PCA were included in the study. The CMR was done 7 to 15 days after the incident. FIS and LVEF were measured by three radiologists who were blinded to clinical information. At 6-8 hours after PCA, total CK and CKMB were assessed in peripheral venous blood. The correlation coefficients were calculated, and the tests were deemed significant when the p value was less than 0.05. The statistical analysis was performed using the software GraphPrism 6.0.

The levels of cardiac biomarkers were shown to have a substantial positive connection with FIS [total CK (r-square 0.3, p0.0001) and CK MB (r-square 0.15, p0.0027)]. Furthermore, there was a strong negative connection between the levels of these biomarkers and LVEF [total CK (r-square 0.3, p0.0001) and CK MB (r-square 0.18, p0.0012)].

Conclusion: These findings support the notion that the myocardial damage biomarkers CK and CKMB are accurate predictors of FIS and LVEF in post-AMI patients evaluated by CMR. These findings point to the possibility of these biomarkers being incorporated in future Risk Scores.

Author (S) Details

Lucía Del Valle-Batalla
Faculty of Medicine, University of Chile, Chile.

Raúl Castillo-Astorga
Faculty of Medicine, University of Chile, Chile.

Rodolfo Prieto-Riveros
Faculty of Medicine, University of Chile, Chile.

Jaime González
Faculty of Medicine, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, University of Chile, Chile.

Rubén Aguayo
San Juan de Dios Hospital, Santiago, Chile.

Kjersti Nes
San Juan de Dios Hospital, Santiago, Chile.

Cristóbal Ramos
University of Chile Clinical Hospital, Santiago, Chile.

Juan Carlos Prieto
University of Chile Clinical Hospital, Santiago, Chile.

Ramón Rodrigo
Faculty of Medicine, Molecular and Clinical Pharmacology Program, Institute of Biomedical Sciences, University of Chile, Chile.

View Book :- https://stm.bookpi.org/NFMMR-V8/article/view/3111